Because of global epidemics of obesity and type 2 diabetes, the prevalence of non-alcoholic
fatty liver disease (NAFLD) is increasing both in Europe and the United States, becoming
one of the most frequent causes of chronic liver disease and predictably, one of the leading
causes of liver transplantation both for end-stage liver disease and hepatocellular
carcinoma. For most transplant teams around the world this will raise many challenges in
terms of pre-and post-transplant management. Here we review the multifaceted impact of …